These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 9861302)

  • 1. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
    Xia QG; Reinecke A; Dorenkamp M; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2006 Nov; 27(11):1417-22. PubMed ID: 17049116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
    Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
    Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure.
    Moe GW; Albernaz A; Naik GO; Kirchengast M; Stewart DJ
    Cardiovasc Res; 1998 Sep; 39(3):571-9. PubMed ID: 9861299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
    Nguyen QT; Cernacek P; Calderoni A; Stewart DJ; Picard P; Sirois P; White M; Rouleau JL
    Circulation; 1998 Nov; 98(21):2323-30. PubMed ID: 9826321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure.
    Thorin E; Lucas M; Cernacek P; Dupuis J
    Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H844-51. PubMed ID: 10924085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional shift of endothelin receptor subtypes in dogs with heart failure produced by rapid ventricular pacing.
    Tadano K; Hosokawa A; Fukuroda T; Nishikibe M
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S350-3. PubMed ID: 15838318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Cazaubon C; Domergue V; Nisato D; Giudicelli JF
    Cardiovasc Res; 1999 Jan; 41(1):100-8. PubMed ID: 10325957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
    Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
    Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.
    Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Hori M
    J Hypertens; 2002 Apr; 20(4):753-61. PubMed ID: 11910313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure.
    Mulder P; Barbier S; Monteil C; Jeng AY; Henry JP; Renet S; Thuillez C
    J Cardiovasc Pharmacol; 2004 Apr; 43(4):489-94. PubMed ID: 15085059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
    Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
    Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling.
    Fraccarollo D; Galuppo P; Bauersachs J; Ertl G
    Cardiovasc Res; 2002 Jun; 54(3):559-67. PubMed ID: 12031701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
    Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
    Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.